NightHawk Biosciences

Morphic Therapeutic Inc is a pioneering biopharmaceutical company based in Waltham, MA, specializing in the development of oral integrin medicines. Leveraging their extensive expertise in integrin biology, they aim to transform treatment paradigms for patients across multiple therapeutic areas, including autoimmune diseases, fibrosis diseases, and cancer. Their lead candidate, MORF-057, is a highly specific inhibitor of 4 7 currently in Phase 2 for inflammatory bowel disease (IBD). With a pipeline that encompasses both novel and highly validated targets, Morphic Therapeutic is committed to drugging integrins through small molecules to address unmet medical needs. They have also established a research partnership with Janssen to discover inhibitors of undisclosed integrin targets, expanding their knowledge of integrin biology into modalities beyond small molecules. Additionally, Morphic is actively developing small molecule inhibitors for the treatment of pulmonary arterial hypertension (PAH), solid tumors, and other indications, utilizing their MInT Platform to create therapeutically relevant compounds with enhanced attributes.Generated from the website

Decibel Therapeutics, Inc. is a Boston-based biotechnology company that is dedicated to addressing the unmet needs of individuals with hearing and balance disorders. With a focus on regenerative and gene therapy strategies, Decibel aims to develop novel therapeutics that can restore hearing and balance, creating meaningful connections for patients and their families. Driven by a passionate team, Decibel Therapeutics is at the forefront of fueling a new field in drug development. Through their pipeline of innovative approaches, including genetic testing resources, the company is committed to making a significant impact in the lives of those affected by hearing and balance disorders.Generated from the website

Arkuda is comprised of passionate and experienced team members who are dedicated to improving the lives of people affected by neurodegenerative disease. Armed with deep expertise in biology and the ab